相关实验视频

Updated: May 6, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

促进痴呆症患者的饮食时间独立和饮食时间体验:一项研究方案

Zhoumei Yan¹, Victoria Traynor^2,3, Ibrahim Alananzeh⁴

¹School of Nursing, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.

|March 24, 2025

概括

这项研究评估了SPREMON干预措施,结合了间隔检索和蒙特利活动,用于养老院痴呆症患者. 这项干预改善了餐时间的独立性,参与度和情绪,解决了西方餐饮礼仪研究中的差距.

科学领域:

老年学是一门学科.
神经科学是一个神经科学.
临床营养学临床营养学

背景情况:

饮食困难对痴呆症患者的福祉有重大影响.
间隔检索和基于蒙特利的干预措施有望改善痴呆症患者的饮食独立性和营养健康.
对于那些坚持西方饮食礼仪的痴呆症患者,这些干预措施的研究有限.

研究的目的:

评估SPREMON (间隔检索和蒙特利活动) 干预措施的有效性.
评估干预措施对餐时间独立性,参与度,情绪和营养状况的影响.
解决关于这些干预措施的知识差距,以西方饮食礼仪为痴呆症老人院居民的背景.

主要方法:

一项涉及痴呆症养老院居民的准实验性研究.
一项为期7周的干预,结合了间隔检索和蒙特利活动,以提高饮食技巧.
在干预前,干预后和3个月后的随访期间收集数据,使用ANOVA或弗里德曼测试进行分析.

主要成果:

在SPREMON干预中,证明了对饮食时间独立的积极影响.
在参与者中观察到餐时间参与和影响 (情绪) 的改善.
该研究提供了有关参与者干预后营养状况的见解.

结论:

这项试点研究弥合了有关使用西方饮食礼仪为痴呆症患者提供空间检索和蒙特利式活动的知识差距.
斯普雷蒙干预措施显示,有潜力增强在痴呆症的养老院居民的饮食时间独立性,参与度和影响力.
需要进一步的研究来证实这些发现,并探索长期影响.

关键词:

影响影响影响影响影响影响.痴呆症痴呆症是一种痴呆症.吃吃吃吃吃吃吃独立生活独立生活独立生活养老院是一个养老院.社会参与参与社会参与

更多相关视频

Concept Development and Use of an Automated Food Intake and Eating Behavior Assessment Method

Concept Development and Use of an Automated Food Intake and Eating Behavior Assessment Method

Published on: February 19, 2021

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...